Search Result "Gliflozin"


Case Report

When Serum C-Peptide Measurement Drives Adequate Diabetes MellitusDiagnosis and Therapy: A Case Report

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 7 Year: 2023 Page: 1003-1007
Author(s):

Review Article

Review on Characteristics and Analytical Methods of RemogliflozinEtabonate: An Update

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 9 Year: 2022 Page: 1341-1350
Author(s): Jagdish K. Sahu,Sanjay Sharma,Vallabh D. Suryavanshi

Review Article

Risks Associated with SGLT2 Inhibitors: An Overview

Journal: Current Drug Safety
Volume: 13 Issue: 2 Year: 2018 Page: 84-91
Author(s): Mahakpreet Singh,Anoop Kumar

Review Article open access plus

Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials

Journal: Current Diabetes Reviews
Volume: 13 Issue: 4 Year: 2017 Page: 405-423
Author(s): Matthew J. Levine

Review Article

Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition

Journal: Current Vascular Pharmacology
Volume: 15 Issue: 2 Year: 2017 Page: 96-102
Author(s): V. Tsimihodimos, T.D. Filippatos, S. Filippas-Ntekouan, M. Elisaf

Editorial free to download

Management of Type 2 Diabetes in Acute Coronary Syndromes: Current State andFuture Perspectives

Journal: Current Pharmaceutical Design
Volume: 29 Issue: 5 Year: 2023 Page: 365-367
Author(s):

Review Article

Canagliflozin : A New Hope in the Antidiabetic Armamentarium

Journal: Recent Patents on Cardiovascular Drug Discovery
Volume: 8 Issue: 3 Year: 2013 Page: 216-220
Author(s): Vasiliki K. Katsi,Christos A. Michalakeas,Charalambos E. Grassos,Georgia D. Vamvakou,John P. Lekakis,Dimitris Tousoulis,Christodoulos I. Stefanadis,Thomas K. Makris,Ioannis E. Kallikazaros

Review Article

Cardiovascular Benefit of SGLT2 Inhibitors in the Therapeutics of Diabetes Mellitus: A Close Look beyond the Horizon

Journal: Current Drug Targets
Volume: 19 Issue: 9 Year: 2018 Page: 1051-1057
Author(s): Dylan Y. Ren,Yingmei Zhang

A Systematic Review on Effect of Canagliflozin in Special Population

Journal: Current Diabetes Reviews
Volume: 12 Issue: 3 Year: 2016 Page: 211-222
Author(s): Sanket Patel,Kalpesh Gohel,Bharat Gordhanbhai Patel

Review Article

SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?

Journal: Current Medicinal Chemistry
Volume: 26 Issue: 2 Year: 2019 Page: 5564-5578
Author(s): Panagiotis I. Georgianos,Maria Divani,Theodoros Eleftheriadis,Peter R. Mertens,Vassilios Liakopoulos

Previous   Next

Go To   Results 1 - 1 of 45

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy